Analyzing Accounts Receivable Lupin Pharmaceuticals, an Indian transnational pharmaceutical company, develops and markets a wide portfolio of branded and generic products. The company reported the following in its 2018 annual report. INR millions 2018 2017 2016 Trade receivables $44,394.7 $36,883.0 $39,054.4 Less provision for doubtful receivables 306.9 318.4 448.2 Trade receivables, net $44,087.8 $36,564.6 $38,606.2 Total assets $140,958 $146,544 $127,375 Revenue from operations 158,042 174,943 142,555 Required a. Calculate days sale outstanding (DSO) for 2018 and 2017. Note: Round amount (your final answer) to one decimal place (for example, enter 6.8 for 6.77555). DSO for 2018 Answer days DSO for 2017 Answer days